There are 2867 resources available
852P - Does sex affect the efficacy of immune checkpoint inhibitors? A national Danish melanoma study
Presenter: Søren Petersen
Session: Poster session 03
1657P - Clinical and molecular profiles of radioiodine refractory differentiated thyroid cancer
Presenter: Yansong Lin
Session: Poster session 11
853P - TNF plasma levels in advanced melanoma patients treated with immune checkpoint inhibitors: Results from the MELANFα clinical study
Presenter: Mathieu Virazels
Session: Poster session 03
1658P - rs4646 is found to be associated with the efficacy of radioiodine (RAI) uptake on thyroid carcinomas: A retrospective study
Presenter: Xin Zhang
Session: Poster session 11
1126P - Project LUMINATE-101: Real-world outcomes of EGFR wildtype (WT) non-squamous (NSQ) locally advanced/metastatic non-small cell lung cancer (aNSCLC) patients receiving docetaxel post frontline (1L) platinum-based chemotherapy in combination with pembrolizumab
Presenter: David Ross Camidge
Session: Poster session 15
854P - Clinical features of acquired resistance (AR) in stage IV melanoma patients (pts) treated with immune checkpoint inhibition (ICI)
Presenter: Judith Versluis
Session: Poster session 03
1659TiP - A Spanish observational study for MOLecular characterization of THYroid carcinoma: MOLTHY Project – TTCC-2020-02
Presenter: Neus Baste Rotllan
Session: Poster session 11
1127P - Efficacy of current immunotherapies in patients (pt) with metastatic non-small cell lung cancer (NSCLC) harboring KRAS mutations
Presenter: Lucia Notario Rincon
Session: Poster session 15
855P - Whole blood transcriptomic profiling to predict response to immunotherapy in metastatic melanoma
Presenter: Rayan Hassaïne
Session: Poster session 03